These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10708933)

  • 1. Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients.
    Hyltander A; Daneryd P; Sandström R; Körner U; Lundholm K
    Eur J Cancer; 2000 Feb; 36(3):330-4. PubMed ID: 10708933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of mechanisms behind elevated energy expenditure in cancer patients with solid tumours.
    Hyltander A; Körner U; Lundholm KG
    Eur J Clin Invest; 1993 Jan; 23(1):46-52. PubMed ID: 8383058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of beta-adrenoceptor agonists and antagonists on heart-rate variability in normal subjects assessed using summary statistics and nonlinear procedures.
    Silke B; Guy S; Riddell JG
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):817-23. PubMed ID: 9436823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise metabolism in healthy volunteers taking celiprolol, atenolol, and placebo.
    Head A; Maxwell S; Kendall MJ
    Br J Sports Med; 1997 Jun; 31(2):120-5. PubMed ID: 9192124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralipid infusion combined with propranolol administration has favorable metabolic effects in elderly malnourished cancer patients.
    Gambardella A; Tortoriello R; Pesce L; Tagliamonte MR; Paolisso G; Varricchio M
    Metabolism; 1999 Mar; 48(3):291-7. PubMed ID: 10094102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol.
    McLeod AA; Brown JE; Kuhn C; Kitchell BB; Sedor FA; Williams RS; Shand DG
    Circulation; 1983 May; 67(5):1076-84. PubMed ID: 6299612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
    Hansen O; Johansson BW; Nilsson-Ehle P
    Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of beta-adrenoceptor blockade on postexercise oxygen consumption and triglyceride/fatty acid cycling.
    Børsheim E; Bahr R; Høstmark AT; Knardahl S
    Metabolism; 1998 Apr; 47(4):439-48. PubMed ID: 9550543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction by beta-adrenoceptor blockade of hypoxia-induced right heart hypertrophy in the rat.
    Ostman-Smith I
    Br J Pharmacol; 1995 Nov; 116(6):2698-702. PubMed ID: 8590992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic and metabolic responses to prolonged exercise after chronic beta 1-adrenoceptor blockade in hypertensive man.
    Frisk-Holmberg M; Juhlin-Dannfelt A; Aström H
    Clin Physiol; 1985 Jun; 5(3):231-42. PubMed ID: 2860992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise capacity, energy metabolism, and beta-adrenoceptor blockade. Comparison between a beta 1-selective and a non-selective beta blocker.
    Verstappen FT; van Baak MA
    Eur J Appl Physiol Occup Physiol; 1987; 56(6):712-8. PubMed ID: 2890520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation.
    Birkenfeld AL; Boschmann M; Moro C; Adams F; Heusser K; Tank J; Diedrich A; Schroeder C; Franke G; Berlan M; Luft FC; Lafontan M; Jordan J
    J Clin Endocrinol Metab; 2006 Dec; 91(12):5069-75. PubMed ID: 16984990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol.
    Horinouchi T; Morishima S; Tanaka T; Suzuki F; Tanaka Y; Koike K; Miwa S; Muramatsu I
    Life Sci; 2007 Jul; 81(5):399-404. PubMed ID: 17628611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral and biochemical studies in rats following prenatal treatment with beta-adrenoceptor antagonists.
    Speiser Z; Gordon I; Rehavi M; Gitter S
    Eur J Pharmacol; 1991 Mar; 195(1):75-83. PubMed ID: 1676680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of catabolism by beta-blockade after severe burns.
    Herndon DN; Hart DW; Wolf SE; Chinkes DL; Wolfe RR
    N Engl J Med; 2001 Oct; 345(17):1223-9. PubMed ID: 11680441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in 't Veld AJ; van Eck HJ; Boomsma F; Schalekamp MA
    Circulation; 1988 Oct; 78(4):957-68. PubMed ID: 3048776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: randomized crossover trial.
    Punda A; Polić S; Rumboldt Z; Bagatin J; Marković V; Lukin A
    Croat Med J; 2005 Apr; 46(2):219-24. PubMed ID: 15849842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise metabolism in healthy volunteers taking atenolol, high and low doses of metoprolol CR/Z0K, and placebo.
    Head A; Maxwell S; Kendall MJ; Eagles C
    Br J Clin Pharmacol; 1994 Dec; 38(6):499-504. PubMed ID: 7888287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.
    Kerr D; MacDonald IA; Heller SR; Tattersall RB
    Br J Clin Pharmacol; 1990 Jun; 29(6):685-93. PubMed ID: 1974143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.